Table 1 Correlation of the expression of LINC01123 in NSCLC with clinicopathologic features
Characteristics | Â | LINC01123 | P value | |
|---|---|---|---|---|
Low and negative (n) | High (n) | Â | ||
Age (years) | ||||
 < 55 | 32 (34.8%) | 17 | 15 | 0.827 |
 ≥ 55 | 60 (65.2%) | 29 | 31 |  |
Gender | ||||
 Male | 51 (55.4%) | 26 | 25 | 0.500 |
 Female | 41 (44.6%) | 20 | 21 |  |
TNM stage | ||||
 I | 49 (53.3%) | 32 | 17 | 0.001** |
 II | 19 (20.7) | 10 | 9 |  |
 III | 22 (23.9%) | 4 | 18 |  |
 IV | 2 (2.2%) | 0 | 2 |  |
T stage | ||||
 T1 | 37 (40.2%) | 21 | 16 | 0.002** |
 T2 | 37 (40.2%) | 21 | 16 |  |
 T3 | 11 (12.0%) | 3 | 8 |  |
 T4 | 7 (7.6%) | 1 | 6 |  |
Lymph node metastasis | ||||
 N0 | 55 (59.8%) | 33 | 22 | 0.002** |
 N1 | 22 (23.9%) | 9 | 13 |  |
 N2 | 11 (12.0%) | 4 | 7 |  |
 N3 | 4 (4.3%) | 0 | 4 |  |
Distant metastasis | ||||
 M0 | 90 (97.8%) | 46 | 44 | 0.495 |
 M1 | 2 (2.2%) | 0 | 2 |  |
Mortality | ||||
 Survive | 41 (44.6%) | 27 | 14 | 0.011* |
Die | 51 (55.4%) | 19 | 32 | Â |
Histological grade | ||||
 I | 2 (2.2%) | 2 | 0 | 0.467 |
 II | 57 (62.0%) | 25 | 32 |  |
 III | 33 (35.9%) | 19 | 14 |  |
Tumor location | ||||
 Left | 43 (46.7%) | 24 | 19 | 0.454 |
 Right | 49 (53.3%) | 22 | 27 |  |